437 related articles for article (PubMed ID: 31495900)
1. Sero-molecular evaluation of Toxoplasma gondii infection among HIV-positive patients.
Ahmadpour E; Pishkarie-Asl R; Spotin A; Samadi Kafil H; Didarlu H; Azadi Y; Barac A
Trans R Soc Trop Med Hyg; 2019 Dec; 113(12):771-775. PubMed ID: 31495900
[TBL] [Abstract][Full Text] [Related]
2. Seroprevalence and risk factors for Toxoplasmosis in HIV infected and non-infected individuals in Bahir Dar, Northwest Ethiopia.
Walle F; Kebede N; Tsegaye A; Kassa T
Parasit Vectors; 2013 Jan; 6(1):15. PubMed ID: 23324409
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of Toxoplasma gondii IgG and IgM antibodies and associated risk factors in women of child-bearing age in Njinikom, NW Cameroon.
Wam EC; Sama LF; Ali IM; Ebile WA; Aghangu LA; Tume CB
BMC Res Notes; 2016 Aug; 9(1):406. PubMed ID: 27528009
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence and risk factors of Toxoplasma gondii infection among healthy blood donors in south-east of Iran.
Mahmoudvand H; Saedi Dezaki E; Soleimani S; Baneshi MR; Kheirandish F; Ezatpour B; Zia-Ali N
Parasite Immunol; 2015 Jul; 37(7):362-7. PubMed ID: 25891186
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence and molecular diagnosis of Toxoplasma gondii infection among blood donors in southern Iran.
Sarkari B; Shafiei R; Zare M; Sohrabpour S; Kasraian L
J Infect Dev Ctries; 2014 Apr; 8(4):543-7. PubMed ID: 24727522
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of IgG and IgM anti-Toxoplasma antibodies in HIV/AIDS patients, northern Iran.
Daryani A; Sharif M; Meigouni M
Asian Pac J Trop Med; 2011 Apr; 4(4):271-4. PubMed ID: 21771468
[TBL] [Abstract][Full Text] [Related]
7. Serological survey and risk factors associated with
Zakari MM; Isah AY; Offiong R; Yunusa T; Abdullahi IN
Malawi Med J; 2020 Sep; 32(3):160-167. PubMed ID: 33488988
[TBL] [Abstract][Full Text] [Related]
8. Serological Evaluation of Toxoplasmosis and Related Risk Factors Among HIV
Rafati-Sajedi H; Majidi-Shad B; Jafari-Shakib R; Atrkar-Roshan Z; Mahmoudi MR; Rezvani SM
Acta Parasitol; 2021 Dec; 66(4):1417-1423. PubMed ID: 34021879
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of
Rezanezhad H; Sayadi F; Shadmand E; Nasab SD; Yazdi HR; Solhjoo K; Kazemi A; Maleki M; Vasmehjani AA
Korean J Parasitol; 2017 Feb; 55(1):99-103. PubMed ID: 28285515
[No Abstract] [Full Text] [Related]
10. Seroprevalence of Toxoplasma gondii infection among HIV-positive patients in Southwest Iran and associated risk factors: a case-control study.
Nikbakht G; Behrouzi M; Mousavizadeh A; Pourabbas B; Rezaei Z; Nouripour-Sisakht S; Arefkhah N
Trans R Soc Trop Med Hyg; 2022 Oct; 116(10):930-934. PubMed ID: 35278090
[TBL] [Abstract][Full Text] [Related]
11. Association of the presence of residual anti-Toxoplasma gondii IgM in pregnant women and their respective family groups in Miracema, Northwest Rio de Janeiro, Brazil.
Ribeiro AC; Mutis MS; Fernandes O
Mem Inst Oswaldo Cruz; 2008 Sep; 103(6):591-4. PubMed ID: 18949330
[TBL] [Abstract][Full Text] [Related]
12. Sero-prevalence of Toxoplasma gondii and associated risk factors among psychiatric outpatients attending University of Gondar Hospital, Northwest Ethiopia.
Achaw B; Tesfa H; Zeleke AJ; Worku L; Addisu A; Yigzaw N; Tegegne Y
BMC Infect Dis; 2019 Jul; 19(1):581. PubMed ID: 31272401
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of Toxoplasma gondii IgG antibody in HIV/AIDS-infected individuals in Maputo, Mozambique.
Domingos A; Ito LS; Coelho E; Lúcio JM; Matida LH; Ramos AN
Rev Saude Publica; 2013 Oct; 47(5):890-6. PubMed ID: 24626493
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of the toxoplasmosis seroprevalence in pregnant women and creating a diagnostic algorithm].
Mumcuoglu I; Toyran A; Cetin F; Coskun FA; Baran I; Aksu N; Aksoy A
Mikrobiyol Bul; 2014 Apr; 48(2):283-91. PubMed ID: 24819265
[TBL] [Abstract][Full Text] [Related]
15. Seromolecular study on the prevalence and risk factors of Toxoplasma gondii infection in pregnant women referred to a gynecology hospital in Urmia, northwest part of Iran in 2022.
Bashour N; Aminpour A; Vazifehkhah S; Jafari R
BMC Infect Dis; 2024 Apr; 24(1):410. PubMed ID: 38632544
[TBL] [Abstract][Full Text] [Related]
16. Investigating the risk factors for seroprevalence and the correlation between CD4+ T-cell count and humoral antibody responses to Toxoplasma gondii infection amongst HIV patients in the Bamenda Health District, Cameroon.
Fang EE; Nyasa RB; Ndi EM; Zofou D; Kwenti TE; Lepezeu EP; Titanji VPK; N Ndip R
PLoS One; 2021; 16(12):e0256947. PubMed ID: 34855762
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of IgG and IgM anti-Toxoplasma gondii Antibodies in Blood Donors at Urmia Blood Transfusion Organization, Iran.
Tappeh KH; Musavi J; Safa MB; Galavani H; Alizadeh H
Turkiye Parazitol Derg; 2017 Mar; 41(1):1-4. PubMed ID: 28483726
[TBL] [Abstract][Full Text] [Related]
18. SEROPREVALENCE OF TOXOPLASMA GONDII INFECTION AMONG PATIENTS ADMITTED TO AL-ZAHRA HOSPITAL, ISFAHAN, IRAN.
Mohaghegh MA; Yazdani H; Hadipour M; Namdar F; Azami M; Kalani H; Mirzaei F; Hejazi SH; Taghavi-Shahri M; Ghomashlooyan M
J Ayub Med Coll Abbottabad; 2015; 27(4):767-70. PubMed ID: 27004318
[TBL] [Abstract][Full Text] [Related]
19. IgG4 specific to Toxoplasma gondii excretory/secretory antigens in serum and/or cerebrospinal fluid support the cerebral toxoplasmosis diagnosis in HIV-infected patients.
Meira CS; Vidal JE; Costa-Silva TA; Motoie G; Gava R; Hiramoto RM; Pereira-Chioccola VL
J Immunol Methods; 2013 Sep; 395(1-2):21-8. PubMed ID: 23811152
[TBL] [Abstract][Full Text] [Related]
20. Molecular diagnosis of Toxoplasma gondii infection in Libya.
Gashout A; Amro A; Erhuma M; Al-Dwibe H; Elmaihub E; Babba H; Nattah N; Abudher A
BMC Infect Dis; 2016 Apr; 16():157. PubMed ID: 27083153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
